11th Alzheimer's and Parkinson's Drug Development Summit Hyatt Centric Fisherman’s Wharf San Francisco, San Francisco

With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map.

Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s and Parkinson’s Drug Development Summit, dedicated to overcoming the translational challenges of targeting neurodegenerative mechanisms. This summit will unite neurodegenerative biopharma experts from discovery, preclinical, translational, and clinical backgrounds to showcase the latest breakthroughs in Alzheimer’s, Parkinson’s, and related neurological disorders in 2022 and 2023.

DATES & VENUE
21 Feb - 23 Feb 2023, 9:00 am - 5:30 pm
#_REVIEWS

OTHER INFORMATION
Go to Event Website
Event Hashtag:
#APDDSummit
Ticket pricing starts from:
Conference + Pre-Conference Workshop Day - Drug Developer: USD 4946.00, Conference + Novel CNS Biomarker Day - Drug Developer: USD 4946.00, Conference Only - Drug Developer: USD 2999.00, Conference + Pre-Conference Workshop Day - Service Provider Pricing: USD 5846.00, Conference + Novel CNS Biomarker Day - Service Provider Pricing: USD 5846.00, Conference Only - Service Provider Pricing: USD 3599.00
TOPICS | CATEGORIES